D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study
- 13 April 2001
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 11 (2) , 105-110
- https://doi.org/10.1016/s0924-977x(00)00133-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Positron Emission Tomography Study of Quetiapine in Schizophrenia: A Preliminary Finding of an Antipsychotic Effect With Only Transiently High Dopamine D2 Receptor OccupancyArchives of General Psychiatry, 2000
- Risperidone and olanzapineInternational Clinical Psychopharmacology, 1998
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- Simplified Reference Tissue Model for PET Receptor StudiesNeuroImage, 1996
- Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET DataJournal of Cerebral Blood Flow & Metabolism, 1996
- ICI 204,636, an Atypical AntipsychoticJournal of Clinical Psychopharmacology, 1996
- Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium AnalysisJournal of Cerebral Blood Flow & Metabolism, 1989
- Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of Rhesus monkeys studied with positron emission tomographyActa Neurologica Scandinavica, 1988
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985
- Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawalPsychopharmacology, 1984